Literature DB >> 7306590

Isolation and properties of prophospholipase A2 from human pancreatic juice.

R Grataroli, A De Caro, O Guy, J Amic, C Figarella.   

Abstract

Human prophospholipase A2 was purified from pancreatic juice. The protein has a molecular weight of 14500 and a free N-terminal residue identified as aspartic acid (or asparagine). The amino acid composition was determined. Partial immunological identity has been obtained between human and porcine prophospholipase A2. As other phospholipases, the human enzyme requires the presence of calcium for its activity. However, the activity of human phospholipase A2 on egg yolk emulsion is partially inhibited at 0.4 mM calcium concentration, which differs from the porcine homologous enzyme. Kinetics of activation of the two zymogens (human and porcine) by 4 different trypsins (bovine, porcine and human) indicate a difference between the two zymogens only when activated by human trypsins, which suggests a marked specificity of both human trypsins for human prophospholipase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306590     DOI: 10.1016/s0300-9084(81)80216-7

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

1.  Effect of trifluoperazine on certain arterial wall lipid-metabolizing enzymes inducing atherosclerosis in rhesus monkeys.

Authors:  A Mohindroo; P Ahluwalia
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

Review 2.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

Review 3.  Acute necrotising pancreatitis--a role for enterokinase.

Authors:  D Grant
Journal:  Int J Pancreatol       Date:  1986-10

Review 4.  Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions.

Authors:  Gianfrancesco Goracci; Monica Ferrini; Vincenza Nardicchi
Journal:  Mol Neurobiol       Date:  2010-03-19       Impact factor: 5.590

5.  Urinary phospholipase A2 excretion in chronic pancreatic diseases.

Authors:  C Fabris; D Basso; M P Panozzo; G Del Favero; T Meggiato; M Plebani; C Ferrara; P Fogar; M Zaninotto; R Naccarato
Journal:  Int J Pancreatol       Date:  1992-06

6.  The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.

Authors:  A De Caro; L Multigner; H Lafont; D Lombardo; H Sarles
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Phosphatidylcholine as substrate for human pancreatic phospholipase A2. Importance of the physical state of the substrate.

Authors:  B Borgström
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

8.  Simultaneous determinations of pancreatic phospholipase A2 and prophospholipase A2 in various pancreatic diseases.

Authors:  A Funakoshi; Y Yamada; Y Migita; H Wakasugi
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

Review 9.  Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2.

Authors:  Ryung Rae Kim; Zheng Chen; Timothy J Mann; Karine Bastard; Kieran F Scott; W Bret Church
Journal:  Molecules       Date:  2020-09-28       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.